QIULING SHI to Neoadjuvant Therapy
This is a "connection" page, showing publications QIULING SHI has written about Neoadjuvant Therapy.
Connection Strength
0.017
-
Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery. Gynecol Oncol. 2019 03; 152(3):501-508.
Score: 0.017